# Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination

> **NCT01485445** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 30 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone Furoate (200mcg unit strength)
- **DRUG:** Fluticasone Furoate/Vilanterol (200/25mcg unit strength)

## Key facts

- **NCT ID:** NCT01485445
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-21
- **Primary completion:** 2012-03-12
- **Final completion:** 2012-03-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485445, "Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01485445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*